Clinical outcome and safety profile of rituximab for the treatment of Dipeptidyl peptidase 4 inhibitors-induced Bullous pemphigoid

  1. Nieto-Benito, L.M.
  2. Bergón-Sendín, M.
  3. Pulido-Pérez, A.
  4. Suárez-Fernández, R.M.
Zeitschrift:
Experimental Dermatology

ISSN: 1600-0625,  0906-6705

Datum der Publikation: 2022

Ausgabe: 31

Nummer: 4

Seiten: 641-642

Art: Brief

DOI: 10.1111/EXD.14483 GOOGLE SCHOLAR lock_openOpen Access editor
Datenquelle: Scopus